BioGaia, a Swedish biotechnology company that develops, markets and sells probiotic products, and Nestlé have signed agreements to extend the collaboration in the field of infant nutrition products.

The European market has recently shown positive momentum, with the STOXX Europe 600 Index rising by 1.91% as investors respond to promising corporate earnings and geopolitical developments such as ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioGaia ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Prior to the new review seven meta-analyses, evaluating different probiotics as well as non-probiotic treatments, have come to the same conclusion; that L.

BioGaia's probiotics have received top ratings and the company has seen rapid growth, but concerns are raised about the company's ability to maintain this amidst leadership changes. The company ...

Net sales amounted to SEK 326.6 million (304.0), an increase of SEK 22.7 million, or an increase of 7% (excluding foreign exchange effects an increase of 14%). Net sales in the Pediatrics segment ...

Earnings call BioGaia reported Q3 2025 sales of SEK 327M, up 7% YoY (14% organic). EBIT more than doubled to SEK 86M, with margin rising to 26% from 14%. Growth was led by U.S. and Asia Pacific, while ...

Often considered as our "second brain", the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous ...

Swedish probiotic biotech company BioGaia is making headway in its short-term mission to attain profitability, reporting a 39 percent increase in sales to SEK 16.4 million for 3Q 2005. Operating ...